BAXTER INTERNATIONAL INC
10-Q, EX-27, 2000-11-14
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: BAXTER INTERNATIONAL INC, 10-Q, EX-15, 2000-11-14
Next: BECTON DICKINSON & CO, 8-K, 2000-11-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED CONSOLIDATED BALANCE SHEET AS OF SEPTEMBER 30, 2000 AND THE CONDENSED
CONSOLIDATED INCOME STATEMENT FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2000 AND
IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                             568
<SECURITIES>                                         0
<RECEIVABLES>                                    1,631
<ALLOWANCES>                                        40
<INVENTORY>                                      1,257
<CURRENT-ASSETS>                                 3,825
<PP&E>                                           4,854
<DEPRECIATION>                                   2,144
<TOTAL-ASSETS>                                   8,808
<CURRENT-LIABILITIES>                            2,446
<BONDS>                                          2,246
                                0
                                          0
<COMMON>                                           298
<OTHER-SE>                                       2,640
<TOTAL-LIABILITY-AND-EQUITY>                     8,808
<SALES>                                          4,964
<TOTAL-REVENUES>                                 4,964
<CGS>                                            2,768
<TOTAL-COSTS>                                    2,768
<OTHER-EXPENSES>                                   293<F1>
<LOSS-PROVISION>                                     5
<INTEREST-EXPENSE>                                  96
<INCOME-PRETAX>                                    582
<INCOME-TAX>                                       114
<INCOME-CONTINUING>                                468
<DISCONTINUED>                                       2
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       470
<EPS-BASIC>                                       1.61
<EPS-DILUTED>                                     1.58
<FN>
<F1>Includes Research and Development Expenses and Goodwill Amortization.
</FN>


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission